Changing the treatment
paradigm

Developing miRNA therapeutics for age-related and fibrotic disorders

Our Technology

Healthy Ageing through musultoskeletal health

MicroRNA therapies have almost limitless therapeutic potential

Our Pipeline

Changing the treatment paradigm

As Causeway’s Tendinopathy program moves into clinical development, we continue to expand our pre-clinical programs focusing on age-related indications that have the potential re-define what it means to grow old.

Programs

As Causeway’s Tendinopathy program moves into clinical development, we continue to expand our pre-clinical programs focusing on age-related indications that have the potential re-define what it means to grow old.

CardioMiR for Heart disease

DermaMiR™
for skin-ageing

TenoMiR
for Tendinopathy

About Us

Our goal is to develop therapies that treat the most common musculoskeletal diseases, such as osteoarthritis and tendinopathy, re-defining what old age looks and feels like.